Linhua Zhang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Magnetic Nanoparticles

Top Venues

ACS biomaterials science & engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyu Yang, Chenlu Huang, Hanyong Wang, Kaiyue Yang, Mingyang Huang, Weijia Zhang, Qingyu Yu, Hai Wang, Linhua Zhang, Rongjun Zhao, Dunwan Zhu
Multifunctional Nanoparticle-Loaded Injectable Alginate Hydrogels with Deep Tumor Penetration for Enhanced Chemo-Immunotherapy of Cancer. ACS nano 18 (28) (2024)
Chenlu Huang, Yu Qin, Shengjie Wu, Qingyu Yu, Lin Mei, Linhua Zhang, Dunwan Zhu
Temperature-Responsive "Nano-to-Micro" Transformed Polymersomes for Enhanced Ultrasound/Fluorescence Dual Imaging-Guided Tumor Phototherapy. Nano letters (2024)
Xinyu Yang, Chenlu Huang, Hanyong Wang, Kaiyue Yang, Mingyang Huang, Weijia Zhang, Qingyu Yu, Hai Wang, Linhua Zhang, Rongjun Zhao, Dunwan Zhu
Multifunctional Nanoparticle-Loaded Injectable Alginate Hydrogels with Deep Tumor Penetration for Enhanced Chemo-Immunotherapy of Cancer. ACS nano (2024)
Chenlu Huang, Yu Qin, Shengjie Wu, Qingyu Yu, Lin Mei, Linhua Zhang, Dunwan Zhu
Temperature-Responsive "Nano-to-Micro" Transformed Polymersomes for Enhanced Ultrasound/Fluorescence Dual Imaging-Guided Tumor Phototherapy. Nano letters 24 (31) (2024)
Yunyi Bo, Linhua Zhang, Zhifeng Wang, Jiafu Shen, Ziwei Zhou, Yan Yang, Yong Wang, Jianglei Qin, Yingna He
Antibacterial Hydrogel with Self-Healing Property for Wound-Healing Applications. ACS biomaterials science & engineering 7 (11) (2021)
Lanxin Qiao, Yu Qin, Yaxin Wang, Yi Liang, Dunwan Zhu, Wei Xiong, Lu Li, Di Bao, Linhua Zhang, Xu Jin
A brain glioma gene delivery strategy by angiopep-2 and TAT-modified magnetic lipid-polymer hybrid nanoparticles. RSC advances 10 (68) (2020)
Linhua Zhang, Shengjie Wu, Yu Qin, Fan Fan, Zhiming Zhang, Chenlu Huang, Weihang Ji, Lu Lu, Chun Wang, Hongfan Sun, Xigang Leng, De Ling Kong, Dunwan Zhu
Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy. Nano letters 19 (7) (2019)